- Home
- MRSN vs MYO Comparison
MRSN vs MYO Comparison
Compare MRSN & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- MYO
- Stock Information
- Founded
- MRSN 2001
- MYO 2004
- Country
- MRSN United States
- MYO United States
- Employees
- MRSN N/A
- MYO N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- MYO Industrial Specialties
- Sector
- MRSN Health Care
- MYO Health Care
- Exchange
- MRSN Nasdaq
- MYO Nasdaq
- Market Cap
- MRSN 47.1M
- MYO 40.8M
- IPO Year
- MRSN 2017
- MYO 2017
- Fundamental
- Price
- MRSN $9.76
- MYO $1.11
- Analyst Decision
- MRSN Strong Buy
- MYO Strong Buy
- Analyst Count
- MRSN 3
- MYO 3
- Target Price
- MRSN $33.00
- MYO $7.83
- AVG Volume (30 Days)
- MRSN 69.2K
- MYO 2.2M
- Earning Date
- MRSN 11-12-2025
- MYO 11-10-2025
- Dividend Yield
- MRSN N/A
- MYO N/A
- EPS Growth
- MRSN N/A
- MYO N/A
- EPS
- MRSN N/A
- MYO N/A
- Revenue
- MRSN $34,769,000.00
- MYO $40,760,091.00
- Revenue This Year
- MRSN N/A
- MYO $24.69
- Revenue Next Year
- MRSN N/A
- MYO $20.91
- P/E Ratio
- MRSN N/A
- MYO N/A
- Revenue Growth
- MRSN 16.14
- MYO 93.08
- 52 Week Low
- MRSN $5.21
- MYO $0.80
- 52 Week High
- MRSN $70.75
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- MRSN 59.67
- MYO 52.00
- Support Level
- MRSN $8.76
- MYO $1.04
- Resistance Level
- MRSN $10.49
- MYO $1.16
- Average True Range (ATR)
- MRSN 0.84
- MYO 0.12
- MACD
- MRSN -0.06
- MYO 0.01
- Stochastic Oscillator
- MRSN 56.87
- MYO 33.87
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).